PDGFB and prostate cancer: Abnormal levels of inflammation-related serum proteins, such as C-X3-C motif chemokine ligand 1, platelet-derived growth factor subunit B homodimer, interleukin 10, C-C motif chemokine ligand (CCL) 21, and CCL 11, were also found to be related to the risk of prostate cancer [20].